Phillip D. Yates

Plasma Protein Binding of Challenging Compounds

Keith Riccardi, Shannon Cawley, Phillip D. Yates et al. · Journal of Pharmaceutical Sciences · 2015 · 117 citations

Pharmacy, Biochemistry, Pharmacology +12

A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling

Rui Li, Hugh A. Barton, Phillip D. Yates et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2014 · 77 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Comparison of Species and Cell-Type Differences in Fraction Unbound of Liver Tissues, Hepatocytes, and Cell Lines

Keith Riccardi, Sangwoo Ryu, Jian Lin et al. · Drug Metabolism and Disposition · 2018 · 43 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition

Rachel J. Roth Flach, Chunyan Su, Eliza Bollinger et al. · PLoS ONE · 2019 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Statistical Methods for Analysis of Time-Dependent Inhibition of Cytochrome P450 Enzymes

Phillip D. Yates, Heather Eng, Li Di et al. · Drug Metabolism and Disposition · 2012 · 31 citations

Pharmacy, Pharmacokinetics, Pharmacology +17